These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 16573776
1. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Shapiro M, Green C, Bautista JM, Peru RL, Malagon IB, Corvo M, Risner-Adler S, Beeler JN, Tuchinsky I, Fass R. Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776 [Abstract] [Full Text] [Related]
2. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis. Yang M, Li ZS, Chen DF, Zou DW, Xu XR, Fang DC, Xu GM, Stephens RL, Wang ZG. Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268 [Abstract] [Full Text] [Related]
4. Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis. Wu JC, Cheung CM, Wong VW, Sung JJ. Clin Gastroenterol Hepatol; 2007 Jun; 5(6):690-5. PubMed ID: 17481961 [Abstract] [Full Text] [Related]
5. [Characteristics of cortical mapping in response to acid exposure in non-erosive reflux disease and erosive esophagitis using functional magnetic resonance imaging]. Yang M, Li ZS, Chen DF, Xu XR, Xu GM, Zou DW, Fang DC. Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):952-6. PubMed ID: 18756965 [Abstract] [Full Text] [Related]
6. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group. Lee KJ, Kwon HC, Cheong JY, Cho SW. Digestion; 2009 Apr 08; 79(3):131-6. PubMed ID: 19307735 [Abstract] [Full Text] [Related]
7. Functional heartburn vs. non-erosive reflux disease: similarities and differences. Hershcovici T, Zimmerman J. Aliment Pharmacol Ther; 2008 Jun 01; 27(11):1103-9. PubMed ID: 18315589 [Abstract] [Full Text] [Related]
9. Increased esophageal sensitivity to acid and saline in patients with nonerosive gastro-esophageal reflux disease. Nagahara A, Miwa H, Minoo T, Hojo M, Kawabe M, Osada T, Kurosawa A, Asaoka D, Terai T, Ohkusa T, Sato N. J Clin Gastroenterol; 2006 Jun 01; 40(10):891-5. PubMed ID: 17063106 [Abstract] [Full Text] [Related]
10. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations]. Soto Pérez JC, Icaza ME, Vargas F, Valdovinos Díaz MA. Rev Gastroenterol Mex; 2003 Jun 01; 68(2):113-9. PubMed ID: 15127647 [Abstract] [Full Text] [Related]
11. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux. Xiong LS, Chen MH, Lin JK, Hu PJ. J Gastroenterol Hepatol; 2008 Feb 01; 23(2):290-5. PubMed ID: 17924953 [Abstract] [Full Text] [Related]
12. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. Savarino E, Tutuian R, Zentilin P, Dulbecco P, Pohl D, Marabotto E, Parodi A, Sammito G, Gemignani L, Bodini G, Savarino V. Am J Gastroenterol; 2010 May 01; 105(5):1053-61. PubMed ID: 19997095 [Abstract] [Full Text] [Related]
13. [Anxiety and depression related to the symptoms of gastroesophageal reflux disease]. Xu ZJ, Duan LP, Wang K, Xia ZW, Lin SR. Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3210-5. PubMed ID: 16405842 [Abstract] [Full Text] [Related]
14. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Savarino E, Zentilin P, Tutuian R, Pohl D, Casa DD, Frazzoni M, Cestari R, Savarino V. Am J Gastroenterol; 2008 Nov 30; 103(11):2685-93. PubMed ID: 18775017 [Abstract] [Full Text] [Related]
15. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn. Frazzoni M, Conigliaro R, Mirante VG, Melotti G. Neurogastroenterol Motil; 2012 Feb 30; 24(2):141-6, e87. PubMed ID: 21988704 [Abstract] [Full Text] [Related]
17. [The roles of Helicobacter pylori and pattern of gastritis in the pathogenesis of reflux esophagitis]. Gao BX, Duan LP, Wang K, Xia ZW, Lin SR. Zhonghua Yi Xue Za Zhi; 2006 Oct 17; 86(38):2674-8. PubMed ID: 17199974 [Abstract] [Full Text] [Related]
18. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease. Hershcovici T, Jha LK, Fass R. J Clin Gastroenterol; 2012 Aug 17; 46(7):562-6. PubMed ID: 22476040 [Abstract] [Full Text] [Related]